Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema: PERMEATE Study

Trial Profile

Peripheral and Macular Retinal Vascular Perfusion and Leakage Dynamics in Diabetic Macular Edema and Retinal Venous Occlusions During Intravitreal Aflibercept Injection (IAI) Treatment for Retinal Edema: PERMEATE Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Diabetic macular oedema; Retinal oedema; Retinal vein occlusion
  • Focus Therapeutic Use
  • Acronyms PERMEATE
  • Most Recent Events

    • 26 Mar 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
    • 26 Mar 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
    • 26 Mar 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top